Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele

References

• DeeksSGLewinSRHavlirDVThe end of AIDS: HIV infection as a chronic diseaseLancet201338299031525153324152939
   PubMed Web of Science ®Google Scholar
• HetheringtonSHughesARMostellerMGenetic variations in HLA-B region and hypersensitivity reactions to abacavirLancet200235993121121112211943262
   PubMed Web of Science ®Google Scholar
• EuropeanEACSClinical SocietyAIDSGuidelines for the treatment of HIV infected adults in Europe. Version 8.2 [webpage on the Internet] Available from http://www.eacsociety.org/guidelines/eacs-guidelines/eacs-guidelines.html (last update 4/10/2016)Accessed May 30, 2017
   Google Scholar
• SorianoVArastehKMigroneHNevirapine versus atazanavir/ritonavir, each combined with tenofovir disoproxil fumarate/emtricitabine, in antiretroviral-naive HIV-1 patients: the ARTEN TrialAntivir Ther201116333934821555816
   PubMed Web of Science ®Google Scholar
• LennoxJLLandovitzRJRibaudoHJEfficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trialAnn Intern Med2014161746147125285539
   PubMed Web of Science ®Google Scholar
• BosmaPJChowdhuryJRBakkerCThe genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndromeN Engl J Med199533318117111757565971
   PubMed Web of Science ®Google Scholar
• GammalRSCourtMHHaidarCEClinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir PrescribingClin Pharmacol Ther201699436336926417955
   PubMed Web of Science ®Google Scholar
• HsiehTYShiuTYHuangSMMolecular pathogenesis of Gilbert’s syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoterPharmacogenet Genomics200717422923617496722
   PubMed Web of Science ®Google Scholar
• KanestriVMironovKKravchenkoAClinical significance of the UGT1A1*28 allele detection in HIV-infected patientsJ Int AIDS Soc2014174 Suppl 31957925394086
   PubMed Web of Science ®Google Scholar
• PanagopoulosPParaskevisDKatsarolisIHigh prevalence of the UGT1A1*28 variant in HIV-infected individuals in GreeceInt J STD AIDS2014251286086524516079
   PubMed Web of Science ®Google Scholar
• KaratzasAGiannatouETzortzisVGenetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian menCancer Epidemiol201034334534920308029
   PubMed Web of Science ®Google Scholar
• TsezouATzetisMGiannatouEGilbert syndrome as a predisposing factor for cholelithiasis risk in the Greek adult populationGenet Test Mol Biomarkers200913114314619309288
   PubMed Web of Science ®Google Scholar
• RibaudoHJDaarESTierneyCImpact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202J Infect Dis2013207342042523148286
   PubMed Web of Science ®Google Scholar
• BustiAJHallRGMargolisDMAtazanavir for the treatment of human immunodeficiency virus infectionPharmacotherapy200424121732174715585441
   PubMed Web of Science ®Google Scholar
• JohnsonDHVenutoCRitchieMDGenomewide association study of atazanavir pharmacokinetics and hyperbilirubinemia in AIDS Clinical Trials Group protocol A5202Pharmacogenet Genomics201424419520324557078
   PubMed Web of Science ®Google Scholar
• JohnsonADKavousiMSmithAVGenome-wide association meta-analysis for total serum bilirubin levelsHum Mol Genet200918142700271019414484
   PubMed Web of Science ®Google Scholar
• ChenGRamosEAdeyemoAUGT1A1 is a major locus influencing bilirubin levels in African AmericansEur J Hum Genet201220446346822085899
   PubMed Web of Science ®Google Scholar
• SannaSBusoneroFMaschioACommon variants in the SLCO1B3 locus are associated with bilirubin levels and unconjugated hyperbilirubinemiaHum Mol Genet200918142711271819419973
   PubMed Web of Science ®Google Scholar
• KangTWKimHJJuHGenome-wide association of serum bilirubin levels in Korean populationHum Mol Genet201019183672367820639394
   PubMed Web of Science ®Google Scholar
• DaiXWuCHeYA genome-wide association study for serum bilirubin levels and gene-environment interaction in a Chinese populationGenet Epidemiol201337329330023371916
   PubMed Web of Science ®Google Scholar
• FerrarisLViganoOPeriASwitching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A1*28 polymorphism carriersJ Antimicrob Chemother20126792236224222661571
   PubMed Web of Science ®Google Scholar
• HarrisMGanaseBWatsonBEfficacy and safety of “unboosting” atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DFHIV Clin Trials2017181394728067119
   PubMed Web of Science ®Google Scholar
• BunupuradahTKiertiburanakulSAvihingsanonALow-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trialLancet HIV201638e34335027470026
   PubMed Web of Science ®Google Scholar
• EstradaVMongeSGomez-GarreMDRelationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapyHIV Med201617965366126935006
   PubMed Web of Science ®Google Scholar
• MorelloJAlvarezECuencaLShort communication: use of serum bilirubin levels as surrogate marker of early virological response to atazanavir-based antiretroviral therapyAIDS Res Hum Retroviruses201127101043104521348813
   PubMed Web of Science ®Google Scholar
• SchackmanBRHaasDWBeckerJECost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV diseaseAntivir Ther201318339940823264445
   PubMed Web of Science ®Google Scholar
• RamanathanSCustodioJMWeiXPharmacokinetics of coformulted Elvitegravir/Cobocistat/Emtricitabine/Tenofovir Disoproxil Fumarate in healthy subjectsJ Acquir Immune Defic Syndr201672328128826885802
   PubMed Web of Science ®Google Scholar
• YaguraHWatanabeDAshidaMCorrelation between UGT1A1 polymorphisms and raltegravir plasma trough concentrations in Japanese HIV-1-infected patientsJ Infect Chemother2015211071371726233886
   PubMed Web of Science ®Google Scholar